Good MorningThe tug of war between the bulls and bears continued on Wednesday leaving the broad market S&P 500 lower for the session. The Dow Jones Industrial Average closed with a smaller loss but the real story is about Tech and Transports. On the one hand, shares of tech heavyweight remain under pressure keeping the NASDAQ Composite behind its peers and down 2.0%. On the other hand, the Dow Jones Transportation Average gained nearly 2.0% at its high to close just shy of another new all-time high.
One reason for the dislocation in trading is rising interest rates. Rising interest rates make growth more costly for the tech sector and that will cut into their earnings. This situation makes the transports and other dividend-paying blue chips more attractive than ever before but the real test for the markets will be on Friday, however, with the release of core consumer inflation data.
Featured: AI Meltdown Imminent: Dump These Stocks Now! (Ad) 
|
Markets | | | When multiple analysts have a favorable opinion on a stock it can be an overwhelming buy signal. Although it doesn't mean the investment doesn't have its risk factors, a green light from an army of Wall Street firms generally means the company has a very bright outlook. Read the Full Story |
|
|
Politics | | | Shares advanced in Asia on Thursday after a broad decline on Wall Street led by selling of tech heavyweights like Facebook and Apple.
Japan’s Nikkei 225 index jumped 0.9%, while other regional benchmarks logged modest gains.
“Asian markets are likely to move sideways ... Read the Full Story |
|
Stocks | | | Similar to how stocks that are related to cryptocurrency, cannabis, and electric vehicles rallied on heavy volume a few months back, we are witnessing new speculative trading activity in companies that are involved in the non-fungible token (NFT) space. Read the Full Story |
|
From Our PartnersJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%...
Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." | | | Click here to watch the demo… |
|
Stocks | | | Despite the bullish outlook for electric vehicles that support a nationwide charging network, Blink Charging is not yet profitable and light on revenue. That’s not a sustainable narrative for BLNK stock. Read the Full Story |
|
Markets | | | World shares were mixed on Thursday and U.S. futures edged higher ahead of the release of the latest unemployment figures.
Paris and Frankfurt declined while Tokyo’s Nikkei 225 index gained 1.1%. Chinese benchmarks stalled on concerns big companies like Alibaba and Tencent might lose... Read the Full Story |
|
|
Markets | | |
Cannabis producer Canopy Growth Corporation (NASDAQ: CGC) stock lost half its value from its 2021 highs during the March Nasdaq correction. Shares are attempting to rebound as marijuana legalization and decriminalization tailwinds continue to accelerate as evidenced by New York is edging closer to... Read the Full Story |
|
Politics | | | Nike. The Gap. Uniqlo. Major clothing and footwear brands are under attack in China after Europe, the U.S. and other countries sanctioned Chinese officials this week over alleged human rights abuses.
The companies, under pressure from activists, have tried to distance themselves from ... Read the Full Story |
|
Markets | | | The Japanese owner of a skyscraper-sized cargo ship wedged across Egypt’s Suez Canal has apologized for the incident that's imperling global shipping.
Shoei Kisen, apologized on Thursday over the “tremendous worry” that the accident has caused to the other vessels and their involved p... Read the Full Story |
|
Politics | | | The former chief science adviser for the U.S. effort to rapidly develop COVID-19 vaccines has been fired from the board of directors of a medical research company over sexual harassment allegations, drugmaker GlaxoSmithKline said Wednesday.
The company said it is firing Moncef Slaoui ... Read the Full Story |
|
Markets | | |
Steelcase Is Why Stock Picking Matters
We don’t want to single out Steelcase (NYSE:SCS) as a bad investment because it’s not. What it is is a uniquely positioned company within a very good industry. While furniture company’s like At Home Group (NYSE: HOME) and Haverty have... Read the Full Story |
|
The Early Bird Stock Of The Day Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing BP1001-A that is in Phase I clinical trial for the treatment of solid tumors; Liposomal Bcl-2 (BP1002), which is in Phase I clinical trial for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; and Liposomal STAT3 (BP1003) for treating pancreatic cancer, non-small cell lung cancer, and AML. The company was founded in 2007 and is based in Bellaire, Texas. | | View Today's Stock Pick |
|
